Gsa Capital Partners LLP Altimmune, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Altimmune, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 339,595 shares of ALT stock, worth $2.8 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

339,595

Previous 488,125 30.43%

Holding current value

$2.8 Million

Previous $3.25 Million 35.77%

% of portfolio

0.16%

Previous 0.23%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$5.5 - $8.1 $816,915 - $1.2 Million	-148,530 Reduced 30.43%	339,595 $2.09 Million
Q2 2024 Aug 15, 2024	BUY	$5.91 - $10.23 $2.58 Million - $4.47 Million	436,972 Added 854.25%	488,125 $3.25 Million
Q1 2024 May 03, 2024	SELL	$8.22 - $13.81 $1.3 Million - $2.19 Million	-158,309 Reduced 75.58%	51,153 $520,000
Q4 2023 Feb 16, 2024	SELL	$2.14 - $11.62 $505,908 - $2.75 Million	-236,406 Reduced 53.02%	209,462 $2.36 Million
Q3 2023 Nov 15, 2023	BUY	$2.4 - $3.45 $647,222 - $930,382	269,676 Added 153.06%	445,868 $1.16 Million
Q2 2023 Aug 14, 2023	SELL	$3.45 - $5.97 $826,833 - $1.43 Million	-239,662 Reduced 57.63%	176,192 $621,000
Q1 2023 May 12, 2023	BUY	$4.19 - $16.83 $1.57 Million - $6.3 Million	374,233 Added 899.14%	415,854 $1.75 Million
Q4 2022 Feb 13, 2023	SELL	$8.74 - $16.45 $8,740 - $16,450	-1,000 Reduced 2.35%	41,621 $685,000
Q3 2022 Nov 14, 2022	SELL	$10.67 - $22.41 $750,058 - $1.58 Million	-70,296 Reduced 62.25%	42,621 $544,000
Q2 2022 Aug 09, 2022	BUY	$3.94 - $11.77 $328,729 - $982,018	83,434 Added 282.99%	112,917 $1.32 Million
Q1 2022 May 11, 2022	SELL	$5.9 - $9.45 $115,132 - $184,407	-19,514 Reduced 39.83%	29,483 $180,000
Q4 2021 Feb 14, 2022	BUY	$8.69 - $12.48 $425,783 - $611,482	48,997 New	48,997 $449,000
Q1 2021 May 10, 2021	SELL	$12.71 - $24.31 $545,576 - $1.04 Million	-42,925 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$7.84 - $14.22 $336,532 - $610,393	42,925 New	42,925 $484,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $404M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Altimmune, Inc. Transaction History